Kidney injury and disease in patients with haematological malignancies
- 30 March 2021
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 17 (6) , 386-401
Abstract
Acute kidney injury (AKI) is common in patients with cancer, especially in those with haematological malignancies. Kidney injury might be a direct consequence of the underlying haematological condition. For example, in the case of lymphoma infiltration or extramedullary haematopoiesis, it might be caused by a tumour product; in the case of cast nephropathy it might be due to the presence of monoclonal immunoglobulin; or it might result from tumour complications, such as hypercalcaemia. Kidney injury might also be caused by cancer treatment, as many chemotherapeutic agents are nephrotoxic. High-intensity treatments, such as high-dose chemotherapy followed by haematopoietic stem cell transplantation, not only increase the risk of infection but can also cause AKI through various mechanisms, including viral nephropathies, engraftment syndrome and sinusoidal obstruction syndrome. Some conditions, such as thrombotic microangiopathy, might also result directly from the haematological condition or the treatment. Novel immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor T cell therapy, can also be nephrotoxic. As new therapies for haematological malignancies with increased anti-tumour efficacy and reduced toxicity are developed, the number of patients receiving these treatments will increase. Clinicians must gain a good understanding of the different mechanisms of kidney injury associated with cancer to better care for these patients.Keywords
This publication has 210 references indexed in Scilit:
- Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent modelJournal of Clinical Investigation, 2012
- The pathogenesis and diagnosis of acute kidney injury in multiple myelomaNature Reviews Nephrology, 2011
- Acute Kidney Injury in Hematopoietic Cell TransplantationSeminars in Nephrology, 2010
- Chronic Kidney Disease, Thrombotic Microangiopathy, and Hypertension Following T Cell-Depleted Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantationBone Marrow Transplantation, 2010
- Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeTransplantation and Cellular Therapy, 2010
- TTP disease course is independent of myeloma treatment and responseAmerican Journal of Hematology, 2010
- Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeEuropean Journal of Haematology, 2008
- Polyomavirus BK infection in blood and marrow transplant recipientsBone Marrow Transplantation, 2007
- Tumour lysis syndrome: new therapeutic strategies and classificationBritish Journal of Haematology, 2004